ischemic heart disease
Conditions
Interventions
Group P(treatment with POBA before DES implantation)
Group R(treatment with Rotablator before DES implantation)
Sponsors
Shinshu University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. more than 20 years old 2. patients who suit the indications of PCI 3. patients who agree with this trial with the informed concent sheet 4. patients who can intake the anti-platelets drugs within a year 5. patients whose coronary artery has significant narrowings in the proximal and mid lesion 6. patients whose reference lesion are 2.75-4.00mm 7. patients who suit the indications of DES
Exclusion criteria
Exclusion criteria: 1. patients of AMI(within 7days) 2. patients who enroll another trials 3. patients who have the history of the side effect of aniplatelet drugs 4. patients who have severe liver disfunction 5. patients whose ejection fraction of LV were less than 40% 6. patients of ACS 7. patients of chronic total occlusion of the target vessel 8. patients of the left main coronary artery disease 9. patients of the triple vessel disease 10 patients of the in-sten restenosis 11. patients whose target lesion are vein bypass graft
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of the target vessel failure(TVF) eight month after prodcedure | — |
Secondary
| Measure | Time frame |
|---|---|
| frequency of the achievment of the ND80% ND80%: minimum lumen diameter/stent diameter >80% (ND80%) | — |
Countries
Japan
Outcome results
None listed